National Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Cancer Research And Biostatistics, Seattle, Washington.
J Thorac Oncol. 2016 Dec;11(12):2089-2099. doi: 10.1016/j.jtho.2016.08.147. Epub 2016 Sep 26.
The current T component for malignant pleural mesothelioma (MPM) has been predominantly informed by surgical data sets and consensus. The International Association for the Study of Lung Cancer undertook revision of the seventh edition of the staging system for MPM with the goal of developing recommendations for the eighth edition.
Data elements including detailed T descriptors were developed by consensus. Tumor thickness at three pleural levels was also recorded. An electronic data capture system was established to facilitate data submission.
A total of 3519 cases were submitted to the database. Of those eligible for T-component analysis, 509 cases had only clinical staging, 836 cases had only surgical staging, and 642 cases had both available. Survival was examined for T categories according to the current seventh edition staging system. There was clear separation between all clinically staged categories except T1a versus T1b (hazard ratio = 0.99, p = 0.95) and T3 versus T4 (hazard ratio = 1.22, p = 0.09), although the numbers of T4 cases were small. Pathological staging failed to demonstrate a survival difference between adjacent categories with the exception of T3 versus T4. Performance improved with collapse of T1a and T1b into a single T1 category; no current descriptors were shifted or eliminated. Tumor thickness and nodular or rindlike morphology were significantly associated with survival.
A recommendation to collapse both clinical and pathological T1a and T1b into a T1 classification will be made for the eighth edition staging system. Simple measurement of pleural thickness has prognostic significance and should be examined further with a view to incorporation into future staging.
目前,恶性胸膜间皮瘤(MPM)的 T 分期主要基于手术数据集和共识。国际肺癌研究协会(IASLC)对 MPM 的分期系统进行了修订,目的是为第八版分期系统制定推荐意见。
通过共识制定了包括详细 T 描述符在内的数据要素。还记录了三个胸膜水平的肿瘤厚度。建立了电子数据采集系统,以方便数据提交。
共有 3519 例病例提交至数据库。在符合 T 分期分析条件的病例中,509 例仅有临床分期,836 例仅有手术分期,642 例两者均有。根据现行的第七版分期系统,对 T 分期进行了生存分析。除 T1a 与 T1b(风险比=0.99,p=0.95)和 T3 与 T4(风险比=1.22,p=0.09)外,所有临床分期类别之间均有明显差异,尽管 T4 病例数较少。病理分期除 T3 与 T4 外,相邻类别之间的生存差异无统计学意义。将 T1a 和 T1b 合并为 T1 类别的方法可提高分期性能;目前没有 T 分期描述符发生改变或被删除。肿瘤厚度和结节状或环状形态与生存显著相关。
建议将临床和病理 T1a 和 T1b 合并为 T1 分类,用于第八版分期系统。胸膜厚度的简单测量具有预后意义,应进一步研究,以期纳入未来的分期。